FlowCAT offers flexible fixed-bed hydrogenation
Bench-top reactor produces results from millilitres of product
HEL, headquartered in Borehamwood, Hertfordshire, UK, has developed a system that delivers high-pressure flow chemistry, with the flexibility to tune hydrogenation conditions to suit the chemistry.
The system design allows for rapid screening of process conditions, which is useful in the early stage generation of API intermediates, where the behaviour and chemistry of the species may be an unknown.
The FlowCAT system is capable of producing results from just a few millilitres of product, but retains the ability to ramp up production volumes once ideal conditions are identified.
At the heart of the system is a tubular reactor with a standard 3mL or 12mL isothermal reaction zone. The system operates up to 400°C and 200Bar. Any heterogeneous catalyst can be used and users can pack their own columns. The wide-bore reactor removes any propensity for blockages and further extends the reliability of the system, the company says.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Measuring tablet film-coating robustness beyond a single setpoint
Read moreMeeting coating setpoints can hide variation between tablets. Linking core attributes, spray, drying and sampling evidence supports reliable scale-up and a defensible operating window
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
As therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part IV)
Real-time monitoring, digital-first platforms and early scalability planning can help manufacturers to maintain quality, flexibility and speed as dosage forms become more sophisticated
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part III)
Early collaboration, specialist purification and carefully targeted investment help manufacturers to bridge development and commercial production, improving process robustness, efficiency and dependable supply